Cambrex

Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle.

The company provides customers with an end-to-end partnership for the research, development and manufacture of small molecule therapeutics. With over 35 years' experience and a growing team of over 2,000 experts servicing global clients from sites in North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and dosage form development and manufacturing.

Cambrex offers a range of specialist drug substance technologies and capabilities including biocatalysis, continuous flow, controlled substances, solid state science, material characterization and highly potent APIs. In addition, Cambrex can support conventional dosage forms including oral solids, semi-solids and liquids and has the expertise to manufacture specialist dosage forms such as modified-release, fixed dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile and non-sterile ointments.

Company video

With over 35 years of active pharmaceutical ingredient development and manufacturing expertise, a growing team of more than 1,200 experts and a strong presence in the USA and Europe, we are tried and trusted across branded and generic API markets.

Drug substance

The drug substance business includes the development, scale-up, technology transfer and manufacturing as well as specialist technologies and capabilities such as biocatalysis, continuous flow, controlled substances, solid state science and handling highly potent APIs.

Custom development and manufacturing

Drug product

The drug product business has expertise in formulation and development of conventional dosage forms including oral solids, semi-solids and liquids, as well as specialist dosage forms such as modified-release, fixed dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile and non-sterile ointments.

Analytical services

Cambrex's early stage development and testing business offers early clinical phase support to customers requiring smaller quantities of drug substance and drug product supply in addition to offering standalone analytical services, including method development and validation, compendial and release testing, stability storage and testing, material characterization, impurity isolation and identification, fate and purge studies, microbiology, cleanroom services and many more.

Webinars

Cambrex have also produced a number of webinars, including:

• Continuous Flow Chemistry for APIs and Intermediates (Part 2 of 2)
• Continuous Flow Chemistry for APIs and Intermediates (Part 1 of 2)
• Highly Potent APIs - Markets, Myths and Manufacturing

View more

Careers

Known for our manufacturing excellence, experience and innovative science, we offer a range of career opportunities across our global network of locations.

As a team, we share one goal - to improve quality of life for our customers' patients across the world.